NHSNContraindicationType

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 3
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2020-08-07T01:00:29-04:00",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "CDC NHSN",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: NHSN surveillance reporting: Contraindication for using chlorhexidine gluconate (CHG) for Central Line Insertion Practices (CLIP) adherence monitoring),(Data Element Scope: A coded observation value representing the type of contraindication.),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "name" : "NHSNContraindicationType",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "code" : "6131-7",
      "display" : "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age",
      "version" : "2023-04"
    }, {
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "code" : "6132-5",
      "display" : "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use",
      "version" : "2023-04"
    }, {
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "code" : "6133-3",
      "display" : "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use",
      "version" : "2023-04"
    } ],
    "total" : 3,
    "identifier" : "urn:uuid:ff169a9b-8654-434f-963d-0ef66e5e92b4",
    "timestamp" : "2024-06-14T18:49:48-04:00"
  },
  "title" : "NHSNContraindicationType",
  "extension" : [ {
    "valueString" : "CDC NHSN Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-02-07",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2020-08-07",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "2.16.840.1.114222.4.11.7239",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7239",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.114222.4.11.7239"
  } ],
  "version" : "20200807"
}